FDA approves record breaking 971 generic drugs in 2018

pharmafile | January 10, 2019 | News story | Manufacturing and Production FDA, approval, generic drugs, generics, regulation 

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in October alone, it has emerged.

The year saw an improvement on the previous record of 937 generics approvals set in 2017. The cost saving medicines were said to have saved consumers as much as $26 billion between January 2017 and July 2018.

As said by FDA commissioner Scott Gottlieb “Over the past two consecutive years, the agency approved record numbers of generic drugs. Now we’re beginning the new fiscal year by breaking another record, this time with the highest number of approved or tentatively approved generics ever in a month.

Through our efforts, generic drugs entering the market from January 2017 through July 2018 saved consumers $26 billion through the lower prices they enabled.”

Louis Goss

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

ZOLL remedē System receives FDA approval for sleep apnoea treatment

ZOLL Medical Corporation has announced that it has received approval from the US Food and …

Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter

US cardiac and vascular surgery company Artivion has announced that the US Food and Drug …

Latest content